We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Aquestive Therapeutics Inc | NASDAQ:AQST | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.02 | 0.57% | 3.54 | 3.32 | 3.54 | 502 | 09:07:32 |
Delaware (State or Other Jurisdiction of Incorporation or Organization) | 30 Technology Drive Warren, NJ 07059 (Address of Principal Executive Offices) (Zip Code) | 82-3827296 (I.R.S. Employer Identification No.) |
Large accelerated filer | ☐ | Accelerated filer | ☐ | ||||||||||||||
Non-accelerated filer | ☒ | Smaller reporting company | ☒ | ||||||||||||||
Emerging growth company | ☒ |
Exhibit Number | Description of Exhibit | |||||||
Aquestive Therapeutics, Inc. 2018 Equity Incentive Plan (filed as Exhibit 10.14 to the Pre-Effective Amendment No. 1, as filed on July 16, 2018, to the Registration Statement on Form S-1 of the Registrant (SEC File No. 333-225924) and incorporated by reference herein). | ||||||||
Legal Opinion of Lori J. Braender, Senior Vice President, General Counsel, and Corporate Secretary, filed herewith | ||||||||
Consent of KPMG LLP, filed herewith. | ||||||||
Powers of Attorney, filed herewith (included on the signature page of this Registration Statement under the caption “Power of Attorney ”). | ||||||||
Filing Fee Table, filed herewith. |
By: | /s/ Daniel R. Barber | ||||
Name: | Daniel R. Barber | ||||
Title: | President and Chief Executive Officer | ||||
Signature | Title | Date | ||||||
/s/ Daniel R. Barber | January 13, 2023 | |||||||
Daniel R. Barber | President, Chief Executive Officer and Member of the Board of Directors | |||||||
(Principal Executive Officer) | ||||||||
/s/ A. Ernest Toth, Jr. | January 13, 2023 | |||||||
A. Ernest Toth, Jr. | Chief Financial Officer | |||||||
(Principal Financial Officer and Principal Accounting Officer) | ||||||||
/s/ Santo J. Costa | January 13, 2023 | |||||||
Santo J. Costa | Chairman of the Board of Directors | |||||||
/s/ Gregory B. Brown, M.D. | January 13, 2023 | |||||||
Gregory B. Brown, M.D. | Member of the Board of Directors | |||||||
/s/ John Cochran | January 13, 2023 | |||||||
John Cochran | Member of the Board of Directors | |||||||
/s/ Julie Krop, M.D. | January 13, 2023 | |||||||
Julie Krop, M.D. | Member of the Board of Directors | |||||||
/s/ Timothy Morris | January 13, 2023 | |||||||
Timothy Morris | Member of the Board of Directors | |||||||
/s/ Marco Taglietti, M.D. | January 13, 2023 | |||||||
Marco Taglietti, M.D. | Member of the Board of Directors |
1 Year Aquestive Therapeutics Chart |
1 Month Aquestive Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions